Blog

Can AI Systems Be GxP Compliant? AI is moving fast in pharma. Companies are using it for adverse event detection, clinical trial monitoring, regulatory submissions, manufacturing quality control, and more. But there is a question that keeps getting pushed to the side: can an AI system actually be GxP compliant? The short answer is yes,

Pharmaceutical companies are under enormous pressure to move faster. AI tools promise exactly that — quicker literature reviews, faster data analysis, sharper clinical insights. So employees use them. Every day, without much thought. And that is where the problem starts. A recent industry study found that only 17% of pharmaceutical organizations have automated controls to

If you are leading a life sciences organization in 2026, you are almost certainly using AI — or actively evaluating it. And if you are operating in a GxP-regulated environment, one question is unavoidable: how do I validate AI? It is the right question to ask. Knowing how to validate AI in pharma is no

As AI reshapes the life sciences industry, data security in the AI-driven environment has become the defining leadership challenge of our time. Every pharma executive, compliance officer, and quality leader is asking the same question: Can we trust AI with our most sensitive data? The answer is not a simple yes or no. It requires

Remote auditing (or e-auditing) is the practice of conducting compliance and quality audits entirely via digital tools, without auditors needing to be on-site. Auditors and clients meet in a virtual environment (for example via Microsoft Teams or Zoom) to share documents, interview staff, and review processes in real time. This method became widely adopted during

Here’s a scenario that plays out more often than anyone in the pharmaceutical industry likes to admit. A pharmaceutical audit is scheduled for five days. Then the site has a shutdown. A key SME goes on leave. The client pushes for an early closeout. Suddenly you are doing a five-day audit in three — and

In 2026, internal audit teams face complex, fast-changing risks. A risk-based auditing approach ensures audits focus on an organization’s highest threats and objectives. This modern method aligns audit planning with enterprise risk management and strategic goals. It moves beyond box-checking to prioritize areas where failures could derail the business. By leveraging tools like AI and

Getting FDA compliance wrong is expensive. A single audit observation can delay product releases, trigger warning letters, or shut down operations entirely.  A computer system validation flow chart removes that uncertainty. It gives your quality, IT, and regulatory teams a shared, documented roadmap — from system planning all the way through retirement.  This guide covers

In today’s digital-first life sciences environment, pharmaceutical, biotech, and medical device companies face relentless regulatory scrutiny. Agencies like the FDA and EMA require firms to demonstrate continuous control of their Good Practice (GxP) processes to ensure product quality, data integrity, and patient safety. Current Good Manufacturing Practice (CGMP) regulations set minimum standards for manufacturing methods

In today’s highly regulated life sciences landscape—encompassing pharmaceuticals, biotechnology, and medical devices—the reliability of computer systems is not merely a technical concern but a fundamental patient safety imperative. Computer System Validation (CSV) serves as the critical bridge between advanced technology and stringent regulatory compliance, ensuring that every system performs its intended function consistently and reliably.